CY1124179T1 - Βελτιωμενη μεθοδος παρασκευης ριβαροξαμπανης με χρηση νεων ενδιαμεσων ενωσεων - Google Patents

Βελτιωμενη μεθοδος παρασκευης ριβαροξαμπανης με χρηση νεων ενδιαμεσων ενωσεων

Info

Publication number
CY1124179T1
CY1124179T1 CY20211100456T CY211100456T CY1124179T1 CY 1124179 T1 CY1124179 T1 CY 1124179T1 CY 20211100456 T CY20211100456 T CY 20211100456T CY 211100456 T CY211100456 T CY 211100456T CY 1124179 T1 CY1124179 T1 CY 1124179T1
Authority
CY
Cyprus
Prior art keywords
rivaroxaban
preparation
improved method
intermediate compounds
new intermediate
Prior art date
Application number
CY20211100456T
Other languages
English (en)
Inventor
Dodda Mohan Rao
Buthukuri Venkat Reddy
Original Assignee
Symed Labs Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symed Labs Limited filed Critical Symed Labs Limited
Publication of CY1124179T1 publication Critical patent/CY1124179T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Abstract

Οι παρόντες εφευρέτες βρήκαν απροσδόκητα ότι η ριβαροξαμπάνη του τύπου Ι μπορεί να παρασκευαστεί με μέθοδο ενός δοχείου, με υψηλή καθαρότητα και υψηλή απόδοση, με αντίδραση 5-χλωροθειοφαιν-2-καρβοξυλικού οξέος ή ενός άλατος αυτού με έναν παράγοντα σουλφονυλίωσης που δίνει έναν ενδιάμεσο σουλφονυλεστέρα, ο οποίος στη συνέχεια συμπυκνώνεται με 4-[4-(SS)-5-(αμινομεθυλο)-2-οξο-1,3-οξαζολιδιν-3-υλ]φαινυλο]μορφολιν-3-όνη ή ένα άλας προσθήκης οξέος αυτής παράγοντας ριβαροξαμπάνη.
CY20211100456T 2012-05-02 2021-05-26 Βελτιωμενη μεθοδος παρασκευης ριβαροξαμπανης με χρηση νεων ενδιαμεσων ενωσεων CY1124179T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2012/000321 WO2013164833A1 (en) 2012-05-02 2012-05-02 Improved process for preparing rivaroxaban using novel intermediates

Publications (1)

Publication Number Publication Date
CY1124179T1 true CY1124179T1 (el) 2022-05-27

Family

ID=49514278

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100456T CY1124179T1 (el) 2012-05-02 2021-05-26 Βελτιωμενη μεθοδος παρασκευης ριβαροξαμπανης με χρηση νεων ενδιαμεσων ενωσεων

Country Status (11)

Country Link
US (1) US9376427B2 (el)
EP (1) EP2844654B1 (el)
CN (1) CN104487436B (el)
AR (1) AR090910A1 (el)
AU (1) AU2012378913B2 (el)
BR (1) BR112014027248B1 (el)
CA (1) CA2871339C (el)
CY (1) CY1124179T1 (el)
ES (1) ES2871811T3 (el)
IL (1) IL235420A (el)
WO (1) WO2013164833A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150218145A1 (en) * 2012-09-26 2015-08-06 Ranbaxy Laboratories Limited Process for the preparation of rivaroxaban
CN103558326B (zh) * 2013-11-12 2014-10-15 江苏正大清江制药有限公司 高效液相色谱法测定利伐沙班片中利伐沙班含量的方法
IN2014MU00072A (el) 2014-01-08 2015-08-21 Wockhardt Ltd
IN2014CH00290A (el) 2014-01-23 2015-08-14 Symed Labs Ltd
CN107778303B (zh) * 2016-08-27 2020-03-24 鲁南制药集团股份有限公司 利伐沙班的精制方法
EP3565552B1 (en) 2017-01-04 2022-05-11 Unichem Laboratories Ltd An improved process for the preparation of rivaroxaban involving novel intermediate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
DE102007028406A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
ES2425183T3 (es) * 2007-08-14 2013-10-11 Concert Pharmaceuticals Inc. Derivados de oxazolidinonas sustituidas
US8309547B2 (en) * 2009-04-28 2012-11-13 Apotex Pharmachem Inc. Processes for the preparation of rivaroxaban and intermediates thereof
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
SI2459555T1 (sl) 2009-07-31 2022-03-31 Krka, D.D., Novo Mesto Postopek kristalizacije rivaroksabana
EP2521723A1 (en) 2010-01-04 2012-11-14 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
EP2388260A1 (de) 2010-05-21 2011-11-23 Archimica GmbH Herstellungsverfahren für einen Inhibitor eines Blutgerinnungsfaktors
WO2012156983A1 (en) 2011-05-16 2012-11-22 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
CN102250077B (zh) * 2011-06-15 2013-11-13 浙江工业大学 一种利伐沙班中间体及其用于合成利伐沙班的方法

Also Published As

Publication number Publication date
WO2013164833A1 (en) 2013-11-07
EP2844654A1 (en) 2015-03-11
US20150126733A1 (en) 2015-05-07
AU2012378913B2 (en) 2017-04-13
US9376427B2 (en) 2016-06-28
ES2871811T3 (es) 2021-11-02
AR090910A1 (es) 2014-12-17
CA2871339C (en) 2016-08-23
EP2844654A4 (en) 2017-12-06
AU2012378913A1 (en) 2014-11-13
CN104487436B (zh) 2017-05-24
BR112014027248A2 (pt) 2017-06-27
IL235420A (en) 2017-02-28
BR112014027248B1 (pt) 2021-01-26
CN104487436A (zh) 2015-04-01
EP2844654B1 (en) 2021-03-10
CA2871339A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
CY1124179T1 (el) Βελτιωμενη μεθοδος παρασκευης ριβαροξαμπανης με χρηση νεων ενδιαμεσων ενωσεων
CY1116958T1 (el) Υποκατεστημενες τριαζολοπυριδινες και η χρηση τους ως ττκ αναστολεις
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
PE20160945A1 (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acetico, composiciones, y usos de las mismas
BR112014015363A8 (pt) derivados de ácido alfa-amino borônico, inibidores de imunoproteassoma seletivos
CR20140464A (es) Compuestos de heterociclilo
CR20140305A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de transtornos inflamatorios
BR112014000471A2 (pt) processo para preparo de derivados de diamida de ácido antranílico substituídos com tetrazol por meio da reação de ácidos pirazóis com ésteres antranílicos
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
CY1123456T1 (el) Μεθοδος παρασκευης οπτικως καθαρων και προαιρετικως υποκατεστημενων παραγωγων 2-(1-υδροξυ-αλκυλ)-χρωμεν-4-ονης και χρηση αυτων στην παρασκευη φαρμακευτικων ουσιων
CO6680645A2 (es) Inhibidores de oxadiazol de la producción de leucotrieno
BR112014016048B8 (pt) Métodos para formação e uso de ésteres de pinacol do ácido 4-cloro-2-flúor-3-substituído-fenilborônico e de 2-(4-cloro-2-flúor-3-metoxifenil)-4,4,5,5-tetrametil1,3,2-dioxaborolano, e éster de pinacol do ácido 4cloro-2-flúor-3-substituído-fenilborônico
EA201391371A1 (ru) Фармацевтическая композиция ситаглиптина
EA201391647A1 (ru) Способ получения ривароксабана и промежуточные соединения, получаемые в указанном способе
CY1117087T1 (el) Διαδικασια για την παρασκευη εστερων (5-φθορο-2-μεθυλο-3-κινολιν-2-υλμεθυλ-ινδoλ-1-υλ)- οξικου οξεος
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
EA201391265A1 (ru) Амиды индолкарбоновых и бензимидазолкарбоновых кислот в качестве инсектицидов и акарицидов
CO6710902A2 (es) Inhibidores de oxadiazol de la producción de leucotrienos
UY32747A (es) 2-carboxamida-cicloamino-ureas sustituidas
AR088358A1 (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos
CU20120087A7 (es) Procedimiento de síntesis y forma cristalina del hidrocloruro de 4-(3-(cis-hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida así como las composiciones farmacéuticas que la contienen
EA201590657A1 (ru) Способ получения высокочистой калиевой соли азилсартана медоксомила
PE20171349A1 (es) Inhibidores de bace1
TR201907568T4 (tr) [5-floro-3-({2-[(4-florobenzen) sülfonil]piridin-3-il}metil)-2-metilindol-1-il]-asetik asidin polimorfik formu.